LRMR

Conviction 20HealthcareScan · Thu, Jun 25, 2026

Three outside down

LRMR$3.49-3.86%

ResistanceSupportVol 14

Vol MA14 2.26M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Larimar Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.larimartx.com ↗

Price3.49

Change-3.86%

Gap-0.28%

Rel volume2.11×

Avg volume2.07M

Avg $ vol7.22M

SMA 203.46

SMA 503.84

SMA 2003.98

Price vs 50-9.09%

Price vs 200-12.32%

MA stackbearish

50/200 crossdeath · 5d

Supertrenddown · 3.77

RSI (14)46

MACD hist0.05

MACD cross—

Stoch %K / %D55 / 69

ADX (14)19

+DI / −DI18 / 15

RSI divergence—

MACD divergence—

ATR %+7.09%

ADR %6.45%

52w high5.95

52w low2.81

From 52w high-41.34%

Above 52w low+24.20%

New 52w highNo

SqueezeOff

Bollinger width18.98%

%B0.55

Donchian pos55.37%

Donchian high3.86

Donchian low3.04

AVWAP (52w high)4.69

vs AVWAP high-25.59%

AVWAP (52w low)4.48

vs AVWAP low-22.11%

OBV trendFlat

Chaikin MF (20)-0.24

Today vs 20d2.11×

Avg vol (14d)2.26M

Avg vol (20d)2.07M

Avg $ vol (20d)7.22M

Market cap362.55M

RS 3m (vs SPY)-32.83%

RS 6m (vs SPY)-8.28%

RS line new highNo

Trend template0/8

Technical rank25.8

1 week-1.41%

1 month+0.58%

3 months-25.43%

6 months-12.75%

1 year+16.72%

YTD+0.58%

P/E-2.19

P/B2.29

P/S—

P/FCF-3.20

EPS-1.32

Div yield—

ROE-104.83%

ROA-79.46%

Debt/Eq0.09

Current4.29

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-105.54%

Price target15.33

Target upside339.26%

Analyst ratingBuy

Institutional87.86%

Ent. value199.18M

Revenue0

Net income-29.61M

Gross profit—

Free cash flow-113.29M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out103.88M

Employees71

ListedFri, May 29, 2020

Free float61.69M

Float %59.4%

Short interest8.05M

Days to cover5.3d

Short volume40.1%

Squeeze score66 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.31 vs −$0.53

Last surprise+41.5% beat

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank25.8 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree outside down

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LRMR

All disclosures →

No recent disclosed trades by Congress in LRMR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LRMR · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Hamilton Thomas Edward Director · Stock Option (Right to Buy) · 2026-05-19	Grant	55.15K	$0	2026-05-19	2026-05-20
SHERMAN JEFFREY W Director · Stock Option (Right to Buy) · 2026-05-19	Grant	55.15K	$0	2026-05-19	2026-05-20
DEERFIELD MANAGEMENT COMPANY, L.P. Director · Stock Option (Right to Buy) · 2026-05-19	Grant	55.15K	$0	2026-05-19	2026-05-20
THOMAS FRANK E Director · Stock Option (Right to Buy) · 2026-05-19	Grant	55.15K	$0	2026-05-19	2026-05-20
Flynn James E Director · Stock Option (Right to Buy) · 2026-05-19	Grant	55.15K	$0	2026-05-19	2026-05-20
Truitt Joseph Director · Stock Option (Right to Buy) · 2026-05-19	Grant	55.15K	$0	2026-05-19	2026-05-20
LEFF JONATHAN S Director · Stock Option (Right to Buy) · 2026-05-19	Grant	55.15K	$0	2026-05-19	2026-05-20

SEC filings

EDGAR filings in LRMR

EDGAR →

No recent SEC filings on file for LRMR.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.